Allspring Global Investments Holdings, LLC Adicet Bio, Inc. Transaction History

Allspring Global Investments Holdings, LLC

$62.1 Billion
Q3 2024

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 23, 2023	SELL	$7.72 - $21.27 $178,123 - $490,762	-23,073 Reduced 49.58%	23,462 $0
Q3 2022 Oct 26, 2022	BUY	$13.43 - $18.74 $618,236 - $862,677	46,034 Added 9188.42%	46,535 $661,000
Q2 2022 Jul 25, 2022	BUY	$10.26 - $20.81 $5,140 - $10,425	501 New	501 $7,000

Others Institutions Holding ACET

# of Institutions

Shares Held

59.2M

Call Options Held

4.2K

Put Options Held

6.7K

Orbimed Advisors LLC San Diego, CA

11.4M
Shares

$10.3 Million
0.39% of portfolio
Tang Capital Management LLC San Diego, CA

8.22M
Shares

$7.4 Million
1.01% of portfolio
Ra Capital Management, L.P. Boston, MA

7.54M
Shares

$6.79 Million
0.15% of portfolio
Goldman Sachs Group Inc New York, NY

3.76M
Shares

$3.38 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

3.21M
Shares

$2.89 Million
0.0% of portfolio

View Full List

About Adicet Bio, Inc.

Ticker ACET
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,030,800
Market Cap $36M
Description
Adicet Bio, Inc., a biotechnology company, discovers and develops allogeneic gamma delta T cell therapies for cancer and other diseases. The company offers gamma delta T cells engineered with chimeric antigen receptors and T cell receptor-like antibodies to enhance selective tumor targeting, facilitate innate and adaptive anti-tumor immune respo...

More about ACET

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Allspring Global Investments Holdings, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Allspring Global Investments Holdings, LLC with notifications on news.

Account